— Know what they know.
Not Investment Advice

GNS.L

Genus plc
1W: -5.1% 1M: -19.5% 3M: +3.3% YTD: -18.9% 1Y: +40.4% 3Y: -2.5% 5Y: -50.4%
£2,485.00 ($33.20)
-40.00 (-1.58%)
 
LSE · Healthcare · Biotechnology · £1.7B · Alpha Radar Sell · Power 36
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap£1.7B ($22.4M)
52W Range1548-3228.8
Volume177,924
Avg Volume195,480
Beta0.85
Dividend£32.90
Analyst Ratings
No analyst coverage
Company Info
CEOJorgen Kokke
Employees3,500
SectorHealthcare
IndustryBiotechnology
IPO Date2000-07-06
Matrix House
Basingstoke RG21 4DZ
GB
44 1256 347 100
About Genus plc

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms